These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 27855998)

  • 41. Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome.
    Compher C; Gilroy R; Pertkiewicz M; Ziegler TR; Ratcliffe SJ; Joly F; Rochling F; Messing B
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5):603-9. PubMed ID: 21825090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Teduglutide in short bowel syndrome patients: A way back to normal life?
    Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
    JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Teduglutide for treatment of adult patients with short bowel syndrome.
    Billiauws L; Bataille J; Boehm V; Corcos O; Joly F
    Expert Opin Biol Ther; 2017 May; 17(5):623-632. PubMed ID: 28293969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
    Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.
    Ramos Boluda E; Redecillas Ferreiro S; Manrique Moral O; García Romero R; Irastorza Terradillos I; Nuñez Ramos R; Germán Díaz M; Polo Miquel B; Vives Piñera I; Alcolea Sánchez A; González Sacristán R; Bautista Barea M; Moreno Villares JM
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):734-739. PubMed ID: 32804906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Teduglutide for the treatment of short bowel syndrome.
    Jeppesen PB
    Drugs Today (Barc); 2013 Oct; 49(10):599-614. PubMed ID: 24191254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome.
    Marier JF; Jomphe C; Peyret T; Wang Y
    Clin Transl Sci; 2021 Nov; 14(6):2497-2509. PubMed ID: 34402197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Schwartz LK; O'Keefe SJ; Fujioka K; Gabe SM; Lamprecht G; Pape UF; Li B; Youssef NN; Jeppesen PB
    Clin Transl Gastroenterol; 2016 Feb; 7(2):e142. PubMed ID: 26844839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome.
    Burness CB; McCormack PL
    Drugs; 2013 Jun; 73(9):935-47. PubMed ID: 23729002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects.
    Vipperla K; O'Keefe SJ
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):683-7. PubMed ID: 24134154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide.
    Fujioka K; Jeejeebhoy K; Pape UF; Li B; Youssef NN; Schneider SM
    JPEN J Parenter Enteral Nutr; 2017 Nov; 41(8):1419-1422. PubMed ID: 27507402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Teduglutide for the treatment of short bowel syndrome.
    Ferrone M; Scolapio JS
    Ann Pharmacother; 2006 Jun; 40(6):1105-9. PubMed ID: 16705029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Teduglutide for the treatment of short bowel syndrome.
    Vipperla K; O'Keefe SJ
    Expert Rev Gastroenterol Hepatol; 2011 Dec; 5(6):665-78. PubMed ID: 22017694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature.
    Pironi L
    JPEN J Parenter Enteral Nutr; 2020 Aug; 44(6):968-978. PubMed ID: 31802516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension.
    Nakamura S; Wada M; Mizushima T; Sugita A; Tazuke Y; Ohge H; Udagawa E; Suzuki RK; Yoon M; Grimm A; Chen ST; Ikeuchi H
    Surg Today; 2023 Mar; 53(3):347-359. PubMed ID: 36201060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption.
    George AT; Li BH; Carroll RE
    Dig Dis Sci; 2019 Jun; 64(6):1599-1603. PubMed ID: 30730014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility.
    Raphael BP; Nurko S; Jiang H; Hart K; Kamin DS; Jaksic T; Duggan C
    J Pediatr Gastroenterol Nutr; 2011 May; 52(5):590-4. PubMed ID: 21502831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.
    Walter E; Dawoud C; Hütterer E; Stift A; Harpain F
    Am J Clin Nutr; 2024 May; 119(5):1187-1199. PubMed ID: 38431119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.